DIAMPA LXR 12.5/2.5/1000MG TAB Carveda Tablet New This combination syrup offers a
DIAMPA LXR 12.5/2.5/1000MG TAB Carveda Tablet New This combination syrup offers aDIAMPA LXR is a triple action antidiabetic tablet combining empagliflozin, linagliptin, and metformin HCl. Each tablet contains 12. 5mg empagliflozin, 2. 5mg linagliptin, and 1000mg metformin HCl, working synergistically to help manage type 2 diabetes mellitus. Empagliflozin promotes glucose excretion through urine, linagliptin inhibits DPP 4 enzyme to enhance insulin secretion, and metformin reduces hepatic glucose production. This combination
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5